David E. Lanfear MD MS
Heart Failure & Transplantation
Section Head, Advanced Heart Failure and Transplantation, Henry Ford Hospital Associate Professor, Internal Medicine, Wayne State University School of Medicine
Join to View Full Profile
Henry Ford Health System2799 West Grand BoulevardDetroit, MI 48202
Phone+1 313-916-9106
Fax+1 313-916-1249
Dr. Lanfear is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Lanfear is a cardiologist in Detroit, MI and is affiliated with Henry Ford Hospital. He received his medical degree from University of Michigan Medical School and has been in practice 19 years. He specializes in heart failure & transplantation and is experienced in echocardiography, cardiac critical care, heart failure and transplantation, vad management, and pharmacogenetics.
Education & Training
University of Michigan School of Public HealthMS, Biostatistics and Research Design, 2005 - 2007
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2001 - 2005- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2001
University of Michigan Medical SchoolClass of 1998
Certifications & Licensure
MI State Medical License 2005 - 2027
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FAHA) American Heart Association, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- Association of plasma metabolites and cardiac mitochondrial function with heart failure progression.Vandana Revathi Venkateswaran, Ruicong She, Stephen J Gardell, Jasmine A Luzum, Ramesh Gupta
ESC Heart Failure. 2025-03-10 - Harnessing the Plasma Proteome to Predict Mortality in Heart Failure Subpopulations.Jessica Chadwick, Michael A Hinterberg, Folkert W Asselbergs, Hannah Biegel, Eric Boersma
Circulation. Heart Failure. 2025-03-07 - Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes.Albert Henry, Xiaodong Mo, Chris Finan, Mark D Chaffin, Doug Speed
Nature Genetics. 2025-03-04
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
- Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndromeDavid E Lanfear 1, Philip G Jones, Sharon Marsh, Sharon Cresci, Howard L McLeod, John A Spertus, JAMA, 9/28/2005
Authored Content
- Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018
- Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018
Press Mentions
Put It on the BoardMay 18th, 2023- Illumina Taps Henry Ford Health System to Explore Whole-Genome Testing for Heart DiseaseApril 17th, 2023
- Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular DiseaseApril 11th, 2023
- Join now to see all
Grant Support
- Development of Polygenic Scores for Medication Response in Diverse PopulationsHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES2024–2026
- Impact Of RACE And Genetic Factors On Beta-Blocker Effectiveness In Heart FailureNational Heart, Lung, And Blood Institute2011–2012
- Pharmacogenetics Of The B-Type Natriuretic Peptide PathwayNational Heart, Lung, And Blood Institute2008–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
